US5310559A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer
Assignee: Hercon Laboratories Corp
•
Filing: 1992-10-21
•
Granted: 1994-05-10
•
Expires: 2012-10-21
Abstract
Abstract Described is a device for the controlled release and delivery to mammalian tissue of a pharmacologically active agent comprising: (i) an impermeable backing member; (ii) a control membrane lamina consisting essentially of a first polymeric composition of matter which consists essentially of at least one C 2 -C 4 lower olefin-C 1 -C 8 alkyl acrylate and/or methacrylate copolymer having 2-90% by weight of alkyl acrylate and/or methacrylate monomeric units, taken alone, or taken further together with in intimate admixture, a second polymeric composition consisting essentially of a C 2 -C 4 polyalkylene corresponding to the C 2 -C 4 lower alkylene of said copolymer, said second polymeric composition being compatible with said first polymeric composition of matter; and (iii) a pharmacologically active agent reservoir maintained there between comprising said pharmacologically active agent and a carrier therefor and, optionally, one or more excipients and/or enhancers; and (iv) means for maintaining said device in pharmacologically active agent transmitting relationship to the mammalian tissue to be treated.
Inventors
- 👤 Kishore Shah
- 👤 Agis Kydonieus
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 15:59
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/70; A61K9/7023; A61K9/703; A61K31/00; A61K31/21; A61K9/7038; A61K9/7046; A61K9/7053; A61K9/7084; A61M; A61M31/00; A61M31/002
Claims Analysis
Total Claims: 34
Claim 1
Independent Claim
261 words
A device for the controlled release and delivery to mammalian tissue of a pharmacologically active agent comprising: (i) at least one polymeric reservoir lamina having a first reservoir lamina surface and, opposite thereto, a second reservoir lamina surface, said reservoir lamina consisting essentially of a first polymeric material and a pharmacologically active agent intimately admixed therewith, (a) said pharmacologically active agent being physically and chemically compatible with said first polymeric material and (b) said first polymeric material being capable of permitting release of said pharmacologically active agent from either said first reservoir lamina surface or said second reservoir lamina surface; and (ii) coated on at least a portion of said first reservoir lamina surface and/or said second reservoir lamina surface sufficient to provide a desired degree of control, a control membrane lamina having a first control membrane lamina surface and, opposite thereto, a second control membrane lamina surface, said control membrane lamina, prior to utilization of said device consisting essentially of a second polymeric material which consists essentially of at least one C 2 -C 4 lower olefin-C 1 -C 8 alkyl acrylate and/or methacrylate copolymer having 2-90% by weight of alkyl acrylate and/or methacrylate monomeric units, taken alone, or taken further together with, in intimate admixture, a third polymeric material consisting essentially of a C 2 -C 4 polyalkylene corresponding to the C 2 -C 4 lower alkylene of said copolymer, said third polymeric material being compatible with said second polymeric material, said control membrane lamina being juxtaposed with said polymeric reservoir lamina at said first control membrane lamina surface.
Claim 2
Independent Claim
261 words
A device for the controlled release and delivery to mammalian tissue of a pharmacologically active agent comprising: (i) at least one polymeric reservoir lamina having a first reservoir lamina surface and, opposite thereto, a second reservoir lamina surface, said reservoir lamina consisting essentially of a first polymeric material and a pharmacologically active agent intimately admixed therewith, (a) said pharmacologically active agent being physically and chemically compatible with said first polymeric material and (b) said first polymeric material being capable of permitting release of said pharmacologically active agent from either said first reservoir lamina surface or said second reservoir lamina surface; and (ii) coated on at least a portion of said first reservoir lamina surface and/or said second reservoir lamina surface sufficient to provide a desired degree of control, a control membrane lamina having a first control membrane lamina surface and, opposite thereto, a second control membrane lamina surface, said control membrane lamina, prior to utilization of said device consisting essentially of a second polymeric material which consists essentially of at least one C 2 -C 4 lower olefin-C 1 -C 8 alkyl acrylate and/or methacrylate copolymer having 2-90% by weight of alkyl acrylate and/or methacrylate monomeric units, taken alone, or taken further together with, in intimate admixture, a third polymeric material consisting essentially of a C 2 -C 4 polyalkylene corresponding to the C 2 -C 4 lower alkylene of said copolymer, said third polymeric material being compatible with said second polymeric material, said control membrane lamina being juxtaposed with said polymeric reservoir lamina at said first control membrane lamina surface.
Claim 3
Dependent Claim
52 words
The device of claim 1 wherein said first polymeric material is plasticized polyvinyl chloride comprising by weight from about 20 up to about 70% of a polyvinyl chloride resin; from about 20 up to about 70% by weight of plasticizer and from about 0.5 up to about 35% of pharmacologically active substance.
Claim 4
Dependent Claim
27 words
The device of claim 1 wherein a backing member lamina, substantially impermeable to said pharmacologically active agent, is adhered to substantially the entire second reservoir lamina surface.
Claim 5
Dependent Claim
12 words
The device of claim 2 wherein the plasticizer is a polymeric plasticizer.
Claim 6
Dependent Claim
12 words
The device of claim 2 wherein the plasticizer is a monomeric plasticizer.
Claim 7
Dependent Claim
28 words
The device of claim 1 wherein the third polymeric material is selected from the group consisting of high density polyethylene, low density polyethylene and linear low density polyethylene.
Claim 8
Dependent Claim
13 words
The device of claim 4 wherein the polymeric plasticizer is epoxidized soybean oil.
Claim 9
Dependent Claim
44 words
The device of claim 1 wherein said second control membrane lamina surface comprises means to maintain skin contact between the skin of an animal to be treated and said second control membrane lamina surface whereby transdermal absorption of said pharmacologically active agent takes place.
Claim 10
Dependent Claim
27 words
The device of claim 2 wherein a backing member lamina, substantially impermeable to said pharmacologically active agent, is adhered to substantially the entire second reservoir lamina surface.
Claim 11
Dependent Claim
27 words
The device of claim 8 wherein said means to maintain skin contact is an adhesive layer for affixing to the skin of the animal to be treated.
Claim 12
Dependent Claim
80 words
The device of claim 1 wherein said second polymeric material contains the repeating monomeric units: ##STR19## wherein R 5 and R 6 are the same or different hydrogen or methyl; wherein R 1 and R 3 are the same or different hydrogen or methyl; wherein R 2 and R 4 are the same or different methyl or ethyl; wherein w, A, B, u and v are integers; and wherein the mole ratio of A+u:B+v varies about 10:90 to about 98:2.
Claim 13
Dependent Claim
24 words
The device of claim 1 wherein said second polymeric material is an ethylene-methyl acrylate copolymer having 2-90% by weight of methyl acrylate monomeric units.
Claim 14
Dependent Claim
36 words
The device of claim 1 wherein the pharmacologically active agent is selected from the group consisting of: (i) clonidine or its salts; (ii) scopolomine or its salts; (iii) timolol; (iv) clenbuterol; (v) nicotine; and (vi) fentanyl.
Claim 15
Dependent Claim
52 words
The device of claim 8 wherein said first polymeric material is plasticized polyvinyl chloride comprising by weight from about 20 up to about 70% of a polyvinyl chloride resin; from about 20 up to about 70% by weight of plasticizer and from about 0.5 up to about 35% of pharmacologically active substance.
Claim 16
Dependent Claim
27 words
The device of claim 14 wherein a backing member lamina, substantially impermeable to said pharmacologically active agent, is adhered to substantially the entire second reservoir lamina surface.
Claim 17
Dependent Claim
12 words
The device of claim 14 wherein the plasticizer is a polymeric plasticizer.
Claim 18
Dependent Claim
12 words
The device of claim 14 wherein the plasticizer is a monomeric plasticizer.
Claim 19
Dependent Claim
13 words
The device of claim 16 wherein the polymeric plasticizer is epoxidized soybean oil.
Claim 20
Dependent Claim
27 words
The device of claim 14 wherein a backing member lamina, substantially impermeable to said pharmacologically active agent, is adhered to substantially the entire second reservoir lamina surface.
Claim 21
Dependent Claim
81 words
The device of claim 14 wherein said second polymeric material contains the repeating monomeric units: ##STR20## wherein R 5 and R 6 are the same or different hydrogen or methyl; wherein R 1 and R 3 are the same or different hydrogen or methyl; wherein R 2 and R 4 are the same or different methyl or ethyl; wherein w, A, B, u and v are integers; and wherein the mole ratio of A+u:B+v varies from about 10:90 to about 98:2.
Claim 22
Dependent Claim
24 words
The device of claim 14 wherein said second polymeric material is an ethylene-methyl acrylate copolymer having 2-90% by weight of methyl acrylate monomeric units.
Claim 23
Dependent Claim
36 words
The device of claim 14 wherein the pharmacologically active agent is selected from the group consisting of: (i) clonidine or its salts; (ii) scopolomine or its salts; (iii) timolol; (iv) clenbuterol; (v) nicotine; and (vi) fentanyl.
Claim 24
Dependent Claim
28 words
The device of claim 14 wherein the third polymeric material is selected from the group consisting of high density polyethylene, low density polyethylene and linear low density polyethylene.
Claim 25
Independent Claim
250 words
A device for the subdermal controlled release and delivery to human tissue of a pharmacologically active agent comprising: (i) at least one polymeric reservoir lamina having a first reservoir lamina surface and, opposite thereto, a second reservoir lamina surface, said reservoir lamina consisting essentially of a first polymeric material and a pharmacologically active agent intimately admixed therewith, (a) said pharmacologically active agent being physically and chemically compatible with said first polymeric material and (b) said first polymeric material being capable of permitting release of said pharmacologically active agent from said first reservoir lamina surface and said second reservoir lamina surface, and (ii) coated on said first reservoir lamina surface and said second reservoir lamina surface, a control membrane lamina having a first control membrane lamina surface and, opposite thereto, a second control membrane lamina surface, said control membrane lamina, prior to utilization of said device consisting essentially of a second polymeric material which consists essentially of at least one C 2 -C 4 lower alkylene-C 1 -C 8 alkyl acrylate and/or methacrylate copolymer having 2-90% by weight of alkyl acrylate and/or methacrylate monomeric units, taken alone, or taken further together with, in intimate admixture, a third polymeric material consisting essentially of a C 2 -C 4 polyalkylene corresponding to the C 2 -C 4 lower alkylene of said copolymer, said third polymeric material being compatible with said second polymeric material, said control membrane lamina being juxtaposed with and surrounding said polymeric reservoir lamina at said first control membrane lamina surface.
Claim 26
Independent Claim
250 words
A device for the subdermal controlled release and delivery to human tissue of a pharmacologically active agent comprising: (i) at least one polymeric reservoir lamina having a first reservoir lamina surface and, opposite thereto, a second reservoir lamina surface, said reservoir lamina consisting essentially of a first polymeric material and a pharmacologically active agent intimately admixed therewith, (a) said pharmacologically active agent being physically and chemically compatible with said first polymeric material and (b) said first polymeric material being capable of permitting release of said pharmacologically active agent from said first reservoir lamina surface and said second reservoir lamina surface, and (ii) coated on said first reservoir lamina surface and said second reservoir lamina surface, a control membrane lamina having a first control membrane lamina surface and, opposite thereto, a second control membrane lamina surface, said control membrane lamina, prior to utilization of said device consisting essentially of a second polymeric material which consists essentially of at least one C 2 -C 4 lower alkylene-C 1 -C 8 alkyl acrylate and/or methacrylate copolymer having 2-90% by weight of alkyl acrylate and/or methacrylate monomeric units, taken alone, or taken further together with, in intimate admixture, a third polymeric material consisting essentially of a C 2 -C 4 polyalkylene corresponding to the C 2 -C 4 lower alkylene of said copolymer, said third polymeric material being compatible with said second polymeric material, said control membrane lamina being juxtaposed with and surrounding said polymeric reservoir lamina at said first control membrane lamina surface.
Claim 27
Independent Claim
190 words
A device for the controlled release and delivery to mammalian tissue of a pharmacologically active agent comprising: (i) an impermeable backing member; (ii) a control membrane lamina consisting essentially of a first polymeric material which consists essentially of at least one C 2 -C 4 lower olefin-C 1 -C 8 alkyl acrylate and/or methacrylate copolymer having 2-90% by weight of alkyl acrylate and/or methacrylate monomeric units, taken alone, or taken further together with, in intimate admixture, a second polymeric material consisting essentially of a C 2 -C 4 polyalkylene corresponding to the C 2 -C 4 lower alkylene of said copolymer, said second polymeric material being compatible with said first polymeric material; (iii) a pharmacologically active agent reservoir maintained therebetween comprising said pharmacologically active agent intimately admixed with a carrier therefor, said pharmacologically active agent being physically and chemically compatible with said first polymeric material and said second polymeric material; said pharmacologically active agent reservoir being capable of permitting release of said pharmacologically active agent from said reservoir through said control membrane lamina; and (iv) means for maintaining said device in pharmacologically active agent transmitting relationship to said mammalian tissue.
Claim 28
Independent Claim
190 words
A device for the controlled release and delivery to mammalian tissue of a pharmacologically active agent comprising: (i) an impermeable backing member; (ii) a control membrane lamina consisting essentially of a first polymeric material which consists essentially of at least one C 2 -C 4 lower olefin-C 1 -C 8 alkyl acrylate and/or methacrylate copolymer having 2-90% by weight of alkyl acrylate and/or methacrylate monomeric units, taken alone, or taken further together with, in intimate admixture, a second polymeric material consisting essentially of a C 2 -C 4 polyalkylene corresponding to the C 2 -C 4 lower alkylene of said copolymer, said second polymeric material being compatible with said first polymeric material; (iii) a pharmacologically active agent reservoir maintained therebetween comprising said pharmacologically active agent intimately admixed with a carrier therefor, said pharmacologically active agent being physically and chemically compatible with said first polymeric material and said second polymeric material; said pharmacologically active agent reservoir being capable of permitting release of said pharmacologically active agent from said reservoir through said control membrane lamina; and (iv) means for maintaining said device in pharmacologically active agent transmitting relationship to said mammalian tissue.
Claim 29
Dependent Claim
33 words
A device of claim 25 wherein a backing member lamina, substantially impermeable to said pharmacologically active agent and said carrier is releasably adhered to substantially the entire surface of said control membrane lamina.
Claim 30
Dependent Claim
81 words
The device of claim 25 wherein said control membrane lamina has a first control membrane lamina surface and opposite thereto a second control membrane lamina surface; and the first control membrane lamina surface is in contact with said pharmacologically active agent reservoir and said second control membrane lamina surface comprises means to maintain skin contact between the skin of an animal to be treated and said second control membrane lamina surface whereby transdermal absorption of said pharmacologically active agent takes place.
Claim 31
Dependent Claim
27 words
The device of claim 27 wherein said means to maintain skin contact is an adhesive layer for affixing to the skin of the animal to be treated.
Claim 32
Dependent Claim
82 words
The device of claim 25 wherein said second polymeric composition of matter contains the repeating monomeric units: ##STR21## wherein R 5 and R 6 are the same or different hydrogen or methyl; wherein R 1 and R 3 are the same or different hydrogen or methyl; wherein R 2 and R 4 are the same or different methyl or ethyl; wherein w, A, B, u and v are integers; and wherein the mole ratio of A+u:B+v varies about 10:90 to about 98:2.
Claim 33
Dependent Claim
13 words
The device of claim 16 wherein the polymeric plasticizer is a polyadipate plasticizer.
Claim 34
Dependent Claim
33 words
The device of claim 1 wherein the first polymeric material is selected from the group consisting of plasticized polyvinyl chloride, a blend of polyisobutenes, and a mixture of polyvinyl alcohol and polyvinyl pyrrolidone.
References Cited (Backward Citations)
CA930668A
Cited
US3996934A
Cited
AT314738B
Cited
DE2314509A1
Cited
DE2362123A1
Cited
US3921636A
Cited
DE2309202A1
Cited
US3965255A
Cited
US4150109A
Cited
CH620122A5
Cited
US4060084A
Cited
US4201211A
Cited
US4356288A
Cited
US4599392A
Cited
EP0139127A1
Cited
GB2155335A
Cited
US4758434A
Cited
EP0186077A2
Cited
US4615699A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-05-09 | 1997-11-08 | 1998-05-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-05-09 | 2001-11-08 | 2002-05-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-05-09 | 2005-11-08 | 2006-05-10 | $7700.00 | Window Closed / Lapsed |